| Name: | Apremilast Impurity 8 |
| Catalogue No. | VE008018 |
| CAS No. | 2096492-44-1 |
| Molecular Formula | C22H24N2O8S |
| Molecular Weight | 476.5 g/mol |
| Status | In-Stock |
| IUPAC Name | (S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-7-hydroxy-1,3-dioxoisoindolin-4-yl)acetamide |
| Description | Apremilast Impurity 8 (CAS NO.-2096492-44-1) IUPAC Name-(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-7-hydroxy-1,3-dioxoisoindolin-4-yl)acetamide. Apremilast is an oral phosphodiesterase 4 inhibitor that has an impact on a wide range of inflammatory mediators involved in psoriasis and psoriatic arthritis, this is the novel treatment that focuses on maintaining a balance between pro-inflammatory and anti-inflammatory signals. |
| References | Schafer, Peter. “Apremilast Mechanism of Action and Application to Psoriasis and Psoriatic Arthritis.” Biochemical Pharmacology, vol. 83, no. 12, June 2012, pp. 1583–90, https://doi.org/10.1016/j.bcp.2012.01.001. |
